Press releases
- Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland
- Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024
- New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System
- Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference
- Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® System
- Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
- Accuray Reports Fiscal 2024 Second Quarter Financial Results
- Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.72 |
---|---|
High | 2.72 |
Low | 2.72 |
Bid | 2.76 |
Offer | 2.78 |
Previous close | 2.72 |
Average volume | -- |
---|---|
Shares outstanding | 99.17m |
Free float | 95.62m |
P/E (TTM) | -- |
Market cap | 219.16m USD |
EPS (TTM) | -0.1496 USD |
Data delayed at least 15 minutes, as of Apr 12 2023.
More ▼